Regencell Bioscience Holdings Ltd - RGC

Sector: Healthcare · Industry: Medicinal Chemicals & Botanical Products
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$13.98M
QoQ value delta ($000)
+$1.275M (+10.03%)
Implied price effect (QoQ)
+35.93%
Shares
Total shares
666,321
QoQ shares delta
-156,790 (-19.05%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (RGC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 36 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 8,674 413,082 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,341 63,900 0.0%
JANE STREET GROUP, LLC 657 31,300 0.0%
Vident Advisory, LLC 628 29,934 0.01%
Squarepoint Ops LLC 546 26,011 0.0%
MORGAN STANLEY 449 21,424 0.0%
UBS Group AG 382 18,203 0.0%
CITADEL ADVISORS LLC 365 17,400 0.0%
XTX Topco Ltd 316 15,081 0.01%
Hudson Bay Capital Management LP 275 13,107 0.0%
GROUP ONE TRADING LLC 111 5,300 0.0%
BlackRock, Inc. 102 4,865 0.0%
Seven Fleet Capital Management LP 92 4,400 0.06%
EverSource Wealth Advisors, LLC 11 550 0.0%
Quarry LP 9 468 0.0%
Farther Finance Advisors, LLC 9 448 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 6 301 0.0%
OSAIC HOLDINGS, INC. 4 227 0.0%
Blue Trust, Inc. 4 216 0.0%
Rockefeller Capital Management L.P. 1 75 0.0%
BANK OF AMERICA CORP /DE/ 0 29 0.0%